Jincheng Pharmaceutical Independent Director Candidate Xu Dechen declares that he meets the qualifications for the position.

China Visit Network data

Shandong Jincheng Pharmaceutical Group Co., Ltd. recently disclosed the statement and undertaking documents of Xu Dechen, an independent director candidate for the seventh session of the board of directors. The statement shows that Xu Dechen has passed the qualification review by the company’s board of directors nomination and appointment committee, and that there is no beneficial or adverse relationship between the nominator and him that could affect independent performance of duties. In his statement, Xu Dechen confirms that he does not have any circumstances prohibited from serving as a director under the Company Law, meets the qualification and conditions for serving as an independent director as set out in the China Securities Regulatory Commission’s “Measures for the Administration of Independent Directors of Listed Companies” and the requirements of the Shenzhen Stock Exchange, and has obtained relevant training certificates.

Xu Dechen undertakes that neither he nor his direct lineal relatives or major social relations hold positions in Jincheng Pharmaceutical or its subsidiaries, and that he does not directly or indirectly hold 1% or more of the company’s issued shares. He is also not among the top ten natural-person shareholders of the company or employed by any of the top five shareholder entities, and he does not hold positions in the subsidiaries of the company’s controlling shareholder or actual controller. At the same time, his statement also indicates that he has not provided financial, legal, consulting, or other services to the company and its related parties, and there is no material business relationship between him and the company and its related parties.

In addition, Xu Dechen confirms that within the most recent 36 months, he has not been subject to criminal or administrative penalties for securities or futures crimes, has not been publicly recognized at a securities trading venue as unsuitable to serve as a director of a listed company, has not been publicly reprimanded by a securities exchange or subjected to more than three instances of notice-and-criticism, and has no record of major dishonesty. The number of domestic listed companies for which he serves as an independent director does not exceed three. His consecutive service at Jincheng Pharmaceutical does not exceed six years. Xu Dechen undertakes that if during his term of office any circumstance arises that fails to meet the qualification requirements for an independent director, he will promptly report and immediately resign, to ensure the compliance and independence of the company’s corporate governance.

Endless information and precise analysis—available in the Sina Finance app